Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
18.16
-0.37 (-2.00%)
Nov 20, 2026, 4:00 PM EST - Market closed
Artivion Revenue
Artivion had revenue of $123.79M in the quarter ending September 30, 2026, with 9.17% growth. This brings the company's total for the last twelve months to $481.88M, up 14.01% year-over-year. In the year 2025, Artivion had annual revenue of $441.33M with 13.59% growth. That makes Artivion the 11,493rd largest company in the world by revenue and 2,319th in the United States.
Revenue (ttm)
$481.88M
Revenue Growth
+14.01%
P/S Ratio
1.84
Revenue / Employee
$267,709
Employees
1,800
Market Cap
886.02M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Artivion breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 441.33M | 52.79M | 13.59% |
| Dec 31, 2024 | 388.54M | 34.53M | 9.75% |
| Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
| Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
| Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
| Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
| Dec 31, 2019 | 276.22M | 13.38M | 5.09% |
| Dec 31, 2018 | 262.84M | 73.14M | 38.55% |
| Dec 31, 2017 | 189.70M | 9.32M | 5.17% |
| Dec 31, 2016 | 180.38M | 34.48M | 23.63% |
| Dec 31, 2015 | 145.90M | 1.26M | 0.87% |
| Dec 31, 2014 | 144.64M | 3.88M | 2.75% |
| Dec 31, 2013 | 140.76M | 9.05M | 6.87% |
| Dec 31, 2012 | 131.72M | 12.09M | 10.11% |
| Dec 31, 2011 | 119.63M | 2.98M | 2.56% |
| Dec 31, 2010 | 116.65M | 4.96M | 4.44% |
| Dec 31, 2009 | 111.69M | 6.63M | 6.31% |
| Dec 31, 2008 | 105.06M | 10.30M | 10.87% |
| Dec 31, 2007 | 94.76M | 13.45M | 16.54% |
| Dec 31, 2006 | 81.31M | 12.03M | 17.36% |
| Dec 31, 2005 | 69.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.44B |
| Integra LifeSciences Holdings | 1.66B |
| Varex Imaging | 865.00M |
| Bioventus | 585.64M |
| InMode | 373.60M |
| OrthoPediatrics | 264.14M |
| SI-BONE | 220.65M |
| Cytek Biosciences | 207.65M |
AORT News
- 9 days ago - Artivion Transcript: Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - Transcripts
- 10 days ago - Artivion Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 14 days ago - Artivion selloff after earnings ‘overdone,’ says Freedom Capital - TheFly
- 14 days ago - Artivion price target lowered to $30 from $40 at Canaccord - TheFly
- 14 days ago - Artivion price target lowered to $40 from $45 at Stifel - TheFly
- 14 days ago - Artivion price target lowered to $42 from $48 at Citizens - TheFly
- 15 days ago - Artivion reports Q3 adjusted EPS 8c, consensus 7c - TheFly
- 15 days ago - Artivion narrows FY26 revenue view to $484M-$492M from $480M-$496M - TheFly